Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Particle Therapy Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for advanced therapies in cancer treatment
5.1.1.2. Rise in adoption of particle therapy in clinical trials
5.1.1.3. Increasing adoption of fast, non-invasive, and painless procedures
5.1.2. Restraints
5.1.2.1. Limited insurance coverage for particle therapy
5.1.3. Opportunities
5.1.3.1. Ongoing proton therapy research programs
5.1.3.2. Technological advances in charged-particle therapy
5.1.4. Challenges
5.1.4.1. Lack of awareness in patients about particle therapy in the emerging economies
5.1.4.2. Risk associated with the particle therapy radiation exposure
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Particle Therapy Market, by Therapy Type
6.1. Introduction
6.2. Fast-Neutron Therapy
6.3. Heavy Ion Therapy
6.4. Proton Therapy

7. Particle Therapy Market, by Component
7.1. Introduction
7.2. Products
7.3.1. Cyclotrons
7.3.2. Synchrocyclotrons
7.3.3. Synchrotrons
7.3. Systems
7.4.1. Multi-Room Systems
7.4.2. Single-Room Systems

8. Particle Therapy Market, by Cancer Type
8.1. Introduction
8.2. Breast Cancer
8.3. Head & Neck Cancer
8.4. Lung Cancer
8.5. Pediatric Cancer
8.6. Prostate Cancer

9. Particle Therapy Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals & Clinics

10. Americas Particle Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Particle Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Particle Therapy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Advanced Oncotherapy plc
14.1.2. Danfysik A/S
14.1.3. Elekta AB
14.1.4. Hitachi, Ltd.
14.1.5. IBA International
14.1.6. Koninklijke Philips N.V.
14.1.7. Mevion Medical Systems
14.1.8. Mitsubishi Electric Corporation
14.1.9. Optivus Proton Therapy, Inc.
14.1.10. ProTom International
14.1.11. Provision Healthcare, LLC
14.1.12. PTW Freiburg GmbH
14.1.13. SAH Global LLC
14.1.14. Sumitomo Heavy Industries, Ltd.
14.1.15. Toshiba Medical Systems Corporation
14.1.16. Varian Medical Systems, Inc.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2022 VS 2030
FIGURE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PARTICLE THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PARTICLE THERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
FIGURE 7. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2030 (%)
FIGURE 8. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
FIGURE 10. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
FIGURE 12. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PARTICLE THERAPY MARKET SIZE, BY FAST-NEUTRON THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 10. PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 12. PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 17. PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 20. PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 49. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 50. CANADA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 51. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 80. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 81. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 82. CHINA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 84. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 86. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 88. INDIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 89. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 90. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 98. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 100. JAPAN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 102. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 134. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 135. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 136. THAILAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 137. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 138. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 159. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 160. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 161. EGYPT PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 165. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 166. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 167. FINLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 174. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 179. GERMANY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 181. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ITALY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 189. ITALY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. ITALY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 191. ITALY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 192. ITALY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 193. ITALY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. NORWAY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 207. NORWAY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 208. NORWAY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 209. NORWAY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 210. NORWAY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. POLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 213. POLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 214. POLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 215. POLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. POLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 217. POLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. QATAR PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 220. QATAR PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 221. QATAR PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. QATAR PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 223. QATAR PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. SPAIN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 243. SPAIN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 244. SPAIN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 245. SPAIN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 247. SPAIN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. TURKEY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 262. TURKEY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 263. TURKEY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 264. TURKEY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 265. TURKEY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 279. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 280. PARTICLE THERAPY MARKET LICENSE & PRICING